Talia İLERİ, Tuğba ERAT, Aysun YAHŞİ, Elif İNCE, Ergin ÇİFTÇİ, Tuğçe TURAL KARA, Halil ÖZDEMİR, Nurdan TAÇYILDIZ, Emel ÜNAL, Erdal İNCE

Bloodstream infections in pediatric hematology/oncology patients: Six years’ experience of a single center in Turkey

Background/aim: Bloodstream infections are the major cause of morbidity, increased cost, prolonged hospitalization, and mortalityin pediatric patients. Identifying the predominant microorganisms and antimicrobial susceptibilities in centers helps to select effectiveempirical antimicrobials which leads to positive clinical outcomes. We aimed to identify the causative microorganisms and theirantimicrobial susceptibilities in patients with bloodstream infections.Materials and methods: Data belonging to patients with hematological and/or oncological diseases admitted to our hospital with feverbetween January 2010 and November 2015 were analyzed.Results: In total, 71 patients who had 111 bloodstream infection episodes were included. Responsible pathogens were detected as follows:35.1% gram-positive microorganisms, 60.5% gram-negative bacteria, and 4.4% fungi. The most common causative gram-negativepathogen was Escherichia coli and the most commonly isolated gram-positive microorganism was coagulase-negative staphylococci.Conclusion: Gram-negative microorganisms were predominant pathogens in bloodstream infections. Escherichia coli and coagulasenegative staphylococci were the most commonly isolated responsible pathogens. Beta-lactam/lactamase inhibitors were suitable forempirical treatment. However, in critical cases, colistin could have been used for empirical treatment until the culture results wereavailable. Routine glycopeptide use was not required. By identifying the causative microorganisms and their antimicrobial resistancepatterns, it will be possible to obtain positive clinical results.

PDF

___

1. Doganis D, Asmar B, Yankelevich M, Thomas R, Ravindranath Y. How many sources should be cultured for the diagnosis of a blood stream infection in children with cancer? Pediatric Hematology and Oncology 2013; 30 (5): 416-424. doi: 10.3109/08880018.2013.783892
2. Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Research Notes 2015; 8: 742. doi: 10.1186/s13104- 015-1701-z
3. Krenn T, Fleischhack G, Moser O, Dilloo D, Bode U et al. Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals. Klinische Pädiatrie 2011; 223 (06): 335-340. doi: 10.1055/s-0031-1287838
4. Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O et al. Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors. Europen Journal of Pediatrics 2015; 174 (5): 675-686. doi: 10.1007/ s00431-015-2525-5
5. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2011; 52 (4): 427-431. doi: 10.1093/cid/ciq147
6. Radhakrishnan V, Vijaykumar V, Ganesan P, Rajendranath R, Trivadi G et al. Bloodstream infections in pediatric patients at cancer institute, Chennai. Indian Journal of Cancer 2014; 51 (4): 418-419. doi: 10.4103/0019-509X.175360
7. Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D et al. Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. Journal of Infection 2014; 68 (4): 321-331. doi: 10.1016/j.jinf.2013
8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009; 49 (1): 1-45. doi: 10.1086/599376
9. Lv H, Ning B. Pathogenesis of bloodstream infection in children with blood cancer. Experimental and Therapeutic Medicine 2013; 5 (1): 201-204. doi: 10.3892/etm.2012.738
10. Abdul Rasool Hassan B, Yusoff ZB, Bin Othman S. Association of neutropenia onset and severity with chemotherapy regimens and schedules. Asian Pacific Journal of Cancer Prevention 2011; 12 (6): 1425-1428.
11. Kuo FC, Wang SM, Shen CF, Ma YJ, Ho TS et al. Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections. Journal of Microbiology, Immunology and Infection 2017; 50 (4): 507-513. doi: 10.1016/j. jmii.2015.08.013
12. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 2002; 34 (6): 730-751. doi: 10.1086/339215
13. Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Israel Medical Association Journal 2007; 9 (6): 424-429.
14. Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH. The spectrum of gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against gram-positive bacteria isolated from cancer patients. International Journal of Infectious Diseases 2006; 10 (3): 223-230. doi: 10.1016/j.ijid.2005.05.007
15. Hazan G, Ben-Shimol S, Fruchtman Y, Abu-Quider A, Kapelushnik J et al. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia. Journal of Pediatric Hematology/Oncology 2014; 36 (5): 275-279. doi: 10.1097/ MPH.0000000000000057.
16. Thacker N, Pereira N, Banavali SD, Narula G, Vora T et al. Epidemiology of blood stream infections in pediatric patients at a Tertiary Care Cancer Centre. Indian Journal of Cancer 2014; 51 (4): 438-441. doi: 10.4103/0019-509X.175311
17. Reddy R, Pathania S, Kapil A, Bakhshi S. Review of spectrum and sensitivity of bacterial bloodstream isolates in children with malignancy: A retrospective analysis from a single center. Indian Journal of Cancer 2014; 51 (4): 425-427. doi: 10.4103/0019- 509X.175363
18. Ye Q, Xu X, Zheng Y, Chen X. Etiology of septicemia in children with acute leukemia: 9-year experience from a children’s hospital in China. Journal of Pediatric Hematology/Oncology 2011; 33 (5): 186-191. doi: 10.1097/MPH.0b013e31821ba92c
19. Celebi S, Sezgin ME, Cakır D, Baytan B, Demirkaya M et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients. Pediatric Hematology and Oncology 2013; 30 (3): 187-194. doi: 10.3109/08880018.2013.772683
20. Kar YD, Özdemir ZC, Bör Ö. Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients. Türk Pediatri Arşivi 2017; 52 (4): 213-220. doi: 10.5152/ TurkPediatriArs.2017.5312
21. Aslan S, Citak EC, Yis R, Degirmenci S, Arman D. Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey. Indian Journal of Microbiology 2012; 52 (2): 203-208. doi: 10.1007/ s12088-011-0210-6
22. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Annals of Internal Medicine 2005; 142 (12_Part_1): 979-995. doi:10.7326/0003-4819-142-12_part_1-200506210-00008
23. Kapoor G, Sachdeva N, Jain S. Epidemiology of bacterial isolates among pediatric cancer patients from a tertiary care oncology center in North India. Indian Journal of Cancer 2014; 51 (4): 420-424. doi: 10.4103/0019-509X.175364
24. Tezcan G, Kupesiz A, Ozturk F, Ogunc D, Gultekin M et al. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Pediatric Hematology and Oncology 2006; 23 (3): 217-229. doi: 10.1080/08880010500506719
25. Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA et al. Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy. Infection and Drug Resistance 2014; 7: 289-299. doi: 10.2147/IDR.S70486
26. Celkan T, Diren S, Ozyilmaz I, Karaman S, Canbolat A et al. The growth rates, isolated agents and their antibiotic resistance in febrile neutropenic attacks between 2000–2004 years. Ankem Dergisi 2006; 20 (1): 4-9.
27. Bassetti M, Righi E. Multidrug-resistant bacteria: what is the threat? American Society of Hematology Education Program 2013; 1: 428-432. doi: 10.1182/asheducation-2013.1.428
28. Kapoor K, Jajoo M, Dublish S, Dabas V, Gupta S et al. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients. Pediatric Critical Care Medicine 2013; 14 (6): 268-272. doi: 10.1097/ PCC.0b013e31828a740f
29. Iosidifis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M et al. Colistin administration to pediatric and neonatal patients. European Journal of Pediatrics 2010; 169 (7): 867-874. doi: 10.1007/s00431-009-1137-3